The Centers for Advanced Surgical Exploration (CASExGLOBAL) announced a partnership with Clinical AI and iOR Partners to introduce CASEx@iOR, the first artificial intelligence (AI)-powered Site Management Organization (SMO) bringing decentralized clinical trials to ophthalmic office-based surgery centers, the company said in a press release. 

Under the leadership of retina specialist Dr. David RP Almeida, this initiative brings together AI and a decentralized trial framework, designed to streamline processes, enhance patient safety and accelerate drug and device development, the company said.

In addition to AI-powered systems, iOR Suites undergo a rigorous accreditation process, making them ideal for decentralized clinical trials. Their accreditation framework ensures that sites meet high standards of quality and performance, further reinforcing the value of this new partnership.

Both companies will showcase their capabilities at the annual American Academy of Ophthalmology meeting in Chicago, October 19-21.